172 related articles for article (PubMed ID: 15039214)
21. Recombinant human growth hormone in patients with HIV-associated wasting. A randomized, placebo-controlled trial. Serostim Study Group.
Schambelan M; Mulligan K; Grunfeld C; Daar ES; LaMarca A; Kotler DP; Wang J; Bozzette SA; Breitmeyer JB
Ann Intern Med; 1996 Dec; 125(11):873-82. PubMed ID: 8967667
[TBL] [Abstract][Full Text] [Related]
22. Altered concentrations of appetite regulators may contribute to the development and maintenance of HIV-associated wasting.
Arnalich F; Martinez P; Hernanz A; González J; Plaza MA; Montiel C; Peña JM; Vázquez JJ
AIDS; 1997 Jul; 11(9):1129-34. PubMed ID: 9233460
[TBL] [Abstract][Full Text] [Related]
23. Safety and efficacy of nandrolone decanoate for treatment of wasting in patients with HIV infection.
Gold J; High HA; Li Y; Michelmore H; Bodsworth NJ; Finlayson R; Furner VL; Allen BJ; Oliver CJ
AIDS; 1996 Jun; 10(7):745-52. PubMed ID: 8805865
[TBL] [Abstract][Full Text] [Related]
24. Transdermal testosterone administration in women with acquired immunodeficiency syndrome wasting: a pilot study.
Miller K; Corcoran C; Armstrong C; Caramelli K; Anderson E; Cotton D; Basgoz N; Hirschhorn L; Tuomala R; Schoenfeld D; Daugherty C; Mazer N; Grinspoon S
J Clin Endocrinol Metab; 1998 Aug; 83(8):2717-25. PubMed ID: 9709937
[TBL] [Abstract][Full Text] [Related]
25. Human hepatic stellate cells express CCR5 and RANTES to induce proliferation and migration.
Schwabe RF; Bataller R; Brenner DA
Am J Physiol Gastrointest Liver Physiol; 2003 Nov; 285(5):G949-58. PubMed ID: 12829440
[TBL] [Abstract][Full Text] [Related]
26. Long-noncoding RNA Atrolnc-1 promotes muscle wasting in mice with chronic kidney disease.
Sun L; Si M; Liu X; Choi JM; Wang Y; Thomas SS; Peng H; Hu Z
J Cachexia Sarcopenia Muscle; 2018 Oct; 9(5):962-974. PubMed ID: 30043444
[TBL] [Abstract][Full Text] [Related]
27. Upregulation of RGS4 expression by IL-1beta in colonic smooth muscle is enhanced by ERK1/2 and p38 MAPK and inhibited by the PI3K/Akt/GSK3beta pathway.
Hu W; Li F; Mahavadi S; Murthy KS
Am J Physiol Cell Physiol; 2009 Jun; 296(6):C1310-20. PubMed ID: 19369446
[TBL] [Abstract][Full Text] [Related]
28. Deletion of IKK2 in hepatocytes does not sensitize these cells to TNF-induced apoptosis but protects from ischemia/reperfusion injury.
Luedde T; Assmus U; Wüstefeld T; Meyer zu Vilsendorf A; Roskams T; Schmidt-Supprian M; Rajewsky K; Brenner DA; Manns MP; Pasparakis M; Trautwein C
J Clin Invest; 2005 Apr; 115(4):849-59. PubMed ID: 15776110
[TBL] [Abstract][Full Text] [Related]
29. [The use of growth hormone to treat endocrine-metabolic disturbances in acquired immunodeficiency syndrome (AIDS) patients].
Spinola-Castro AM; Siviero-Miachon AA; da Silva MT; Guerra-Junior G
Arq Bras Endocrinol Metabol; 2008 Jul; 52(5):818-32. PubMed ID: 18797589
[TBL] [Abstract][Full Text] [Related]
30. Interleukin-1beta up-regulates RGS4 through the canonical IKK2/IkappaBalpha/NF-kappaB pathway in rabbit colonic smooth muscle.
Hu W; Li F; Mahavadi S; Murthy KS
Biochem J; 2008 May; 412(1):35-43. PubMed ID: 18260825
[TBL] [Abstract][Full Text] [Related]
31. ALPK1 regulates streptozotocin-induced nephropathy through CCL2 and CCL5 expressions.
Lee CP; Nithiyanantham S; Hsu HT; Yeh KT; Kuo TM; Ko YC
J Cell Mol Med; 2019 Nov; 23(11):7699-7708. PubMed ID: 31557402
[TBL] [Abstract][Full Text] [Related]
32. Hepatocyte IKK2 protects Mdr2-/- mice from chronic liver failure.
Ehlken H; Kondylis V; Heinrichsdorff J; Ochoa-Callejero L; Roskams T; Pasparakis M
PLoS One; 2011; 6(10):e25942. PubMed ID: 22022477
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of human immunodeficiency virus type 1 replication by a bioavailable serine/threonine kinase inhibitor, fasudil hydrochloride.
Sato T; Asamitsu K; Yang JP; Takahashi N; Tetsuka T; Yoneyama A; Kanagawa A; Okamoto T
AIDS Res Hum Retroviruses; 1998 Mar; 14(4):293-8. PubMed ID: 9519889
[TBL] [Abstract][Full Text] [Related]
34. Different plasma levels of interleukins and chemokines: comparison between children and adults with AIDS in China.
Jin CZ; Zhao Y; Zhang FJ; Yao HP; Wu LJ; Zhao HX; Wei HS; Wu NP
Chin Med J (Engl); 2009 Mar; 122(5):530-5. PubMed ID: 19323903
[TBL] [Abstract][Full Text] [Related]
35. IkappaB kinase-independent IkappaBalpha degradation pathway: functional NF-kappaB activity and implications for cancer therapy.
Tergaonkar V; Bottero V; Ikawa M; Li Q; Verma IM
Mol Cell Biol; 2003 Nov; 23(22):8070-83. PubMed ID: 14585967
[TBL] [Abstract][Full Text] [Related]
36. GW274150, a potent and highly selective inhibitor of iNOS, reduces experimental renal ischemia/reperfusion injury.
Chatterjee PK; Patel NS; Sivarajah A; Kvale EO; Dugo L; Cuzzocrea S; Brown PA; Stewart KN; Mota-Filipe H; Britti D; Yaqoob MM; Thiemermann C
Kidney Int; 2003 Mar; 63(3):853-65. PubMed ID: 12631066
[TBL] [Abstract][Full Text] [Related]
37. The Rho-kinase pathway regulates angiotensin II-induced renal damage.
Rupérez M; Sánchez-López E; Blanco-Colio LM; Esteban V; Rodríguez-Vita J; Plaza JJ; Egido J; Ruiz-Ortega M
Kidney Int Suppl; 2005 Dec; (99):S39-45. PubMed ID: 16336575
[TBL] [Abstract][Full Text] [Related]
38. Targeting NF-kappaB pathway with an IKK2 inhibitor induces inhibition of multiple myeloma cell growth.
Jourdan M; Moreaux J; Vos JD; Hose D; Mahtouk K; Abouladze M; Robert N; Baudard M; Rème T; Romanelli A; Goldschmidt H; Rossi JF; Dreano M; Klein B
Br J Haematol; 2007 Jul; 138(2):160-8. PubMed ID: 17542984
[TBL] [Abstract][Full Text] [Related]
39. The etiology of wasting in the human immunodeficiency virus and acquired immunodeficiency syndrome.
Strawford A; Hellerstein M
Semin Oncol; 1998 Apr; 25(2 Suppl 6):76-81. PubMed ID: 9625388
[TBL] [Abstract][Full Text] [Related]
40. Complete lack of NF-kappaB activity in IKK1 and IKK2 double-deficient mice: additional defect in neurulation.
Li Q; Estepa G; Memet S; Israel A; Verma IM
Genes Dev; 2000 Jul; 14(14):1729-33. PubMed ID: 10898787
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
